Prudence Dorazio

642 total citations
7 papers, 506 citations indexed

About

Prudence Dorazio is a scholar working on Oncology, Pharmacology and Epidemiology. According to data from OpenAlex, Prudence Dorazio has authored 7 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Pharmacology and 2 papers in Epidemiology. Recurrent topics in Prudence Dorazio's work include Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Prudence Dorazio is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Prudence Dorazio collaborates with scholars based in United States, Italy and Canada. Prudence Dorazio's co-authors include Diane Healey, Jesús Gómez-Navarro, Alan P. Venook, Leonard B. Saltz, Ki Y. Chung, Lawrence Fong, Bo Huang, Ira Gore, Susan M. Domchek and Jens Rüter and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and PubMed.

In The Last Decade

Prudence Dorazio

7 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prudence Dorazio United States	6	450	296	67	54	41	7	506
Wolfgang Moersig Germany	7	336 0.7×	251 0.8×	87 1.3×	20 0.4×	60 1.5×	12	432
Christian Quack Germany	3	359 0.8×	497 1.7×	26 0.4×	27 0.5×	86 2.1×	7	636
Osamu Kawai Japan	7	288 0.6×	235 0.8×	82 1.2×	17 0.3×	49 1.2×	10	374
Francesca Bergomas Italy	6	337 0.7×	333 1.1×	49 0.7×	46 0.9×	76 1.9×	7	469
Stefania Laurent Italy	7	322 0.7×	284 1.0×	43 0.6×	13 0.2×	65 1.6×	10	448
Jason Cham United States	8	272 0.6×	173 0.6×	84 1.3×	22 0.4×	61 1.5×	20	355
Mu Yan Cai China	7	190 0.4×	187 0.6×	57 0.9×	22 0.4×	115 2.8×	7	392
Lauren M. Eastman United States	4	350 0.8×	251 0.8×	66 1.0×	17 0.3×	107 2.6×	6	434
Stephanie Mittman United States	6	356 0.8×	377 1.3×	49 0.7×	18 0.3×	90 2.2×	7	516
Hannah L. Williams United Kingdom	5	287 0.6×	159 0.5×	94 1.4×	45 0.8×	105 2.6×	10	440

Countries citing papers authored by Prudence Dorazio

Since Specialization

Citations

This map shows the geographic impact of Prudence Dorazio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence Dorazio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence Dorazio more than expected).

Fields of papers citing papers by Prudence Dorazio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prudence Dorazio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence Dorazio. The network helps show where Prudence Dorazio may publish in the future.

Co-authorship network of co-authors of Prudence Dorazio

This figure shows the co-authorship network connecting the top 25 collaborators of Prudence Dorazio. A scholar is included among the top collaborators of Prudence Dorazio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prudence Dorazio. Prudence Dorazio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Vonderheide, Robert H., Patricia LoRusso, Magi Khalil, et al.. (2010). Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells. Clinical Cancer Research. 16(13). 3485–3494. 234 indexed citations

2.

Chung, Ki Y., Ira Gore, Lawrence Fong, et al.. (2010). Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer. Journal of Clinical Oncology. 28(21). 3485–3490. 238 indexed citations

3.

Vonderheide, Robert H., Patricia LoRusso, Elisabeth I. Heath, et al.. (2009). Tremelimumab in combination with exemestane as novel immunotherapy for patients with advanced breast cancer. Journal of Clinical Oncology. 27(15_suppl). 3034–3034. 3 indexed citations

4.

Bulanhagui, C. A., Prudence Dorazio, Diane Healey, et al.. (2008). Safety of tremelimumab (CP-675,206) in patients (pts) with advanced cancer. Journal of Clinical Oncology. 26(15_suppl). 3040–3040. 8 indexed citations

5.

Chung, Ki Y., Ira Gore, Lawrence Fong, et al.. (2007). A phase II study of the anti-CTLA4 monoclonal antibody (mAb), CP-675,206, in patients with refractory metastatic adenocarcinoma of the colon or rectum. Journal of Clinical Oncology. 25(18_suppl). 3035–3035. 6 indexed citations

6.

Stefanelli, Paola, et al.. (1999). Characterization of Bordetella pertussis strains of recent isolation.. PubMed. 22(3). 187–94. 6 indexed citations

7.

Giuliano, Marina, et al.. (1997). Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines.. PubMed. 89. 275–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact